[1] Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD. Psilocybin-assisted therapy for depression: a systematic review and meta-analysis[J]. Psychiatry Res, 2023, 329:115531. [2] Kong X, Wu Y, Wang X, Sun Y, Chen K, Li Q, Li J. Analysis of the prevalence and influencing factors of anxiety and depression in the Chinese population: a cross-sectional survey [J]. Heliyon, 2023, 9:e15889. [3] Liu C, Zhao N, Dong Y. Editorial: basic and clinical research on neurostimulation techniques in major depressive disorder[J]. Front Psychiatry, 2023, 14:1287617. [4] Gillving C, Arnison T, Nordenskjöld A. Outcomes of ECT for depression in patients with and without eating disorders[J]. J Psychiatr Res, 2025, 183:308-312. [5] Tegeler CL, Haight TJ, Cole WR, Shaltout HA, Choi YS, Harris TE, Rachels N, Bellini PG, Roy MJ, Tegeler CH. Acoustic neuromodulation with or without micro-voltage tACS reduces post-concussive symptoms[J]. Brain Inj, 2025, 39:496-508. [6] Johnson KA, Okun MS, Scangos KW, Mayberg HS, de Hemptinne C. Deep brain stimulation for refractory major depressive disorder: a comprehensive review [J]. Mol Psychiatry, 2024, 29:1075-1087. [7] Wischnewski M, Alekseichuk I, Opitz A. Neurocognitive, physiological, and biophysical effects of transcranial alternating current stimulation[J]. Trends Cogn Sci, 2023, 27:189-205. [8] Guo Q, Wang Y, Guo L, Li X, Ma X, He X, Li J, Zhang X, Shang S. Long-term cognitive effects of electroconvulsive therapy in major depressive disorder: a systematic review and meta-analysis[J]. Psychiatry Res, 2024, 331:115611. [9] Mutz J. Brain stimulation treatment for bipolar disorder[J]. Bipolar Disord, 2023, 25:9-24. [10] Yan J, Zhang Y, Wang J, Zhu G, Fang K. Effects of transcranial magnetic stimulation on sleep structure and quality in children with autism[J]. Front Psychiatry, 2024, 15:1413961. [11] Sheth SA, Mayberg HS. Deep brain stimulation for obsessive-compulsive disorder and depression[J]. Annu Rev Neurosci, 2023, 46:341-358. [12] Wang X, Hu R, Wang T, Chang Y, Liu X, Li M, Gao Y, Liu S, Ming D. Resting-state electroencephalographic signatures predict treatment efficacy of tACS for refractory auditory hallucinations in schizophrenic patients[J]. IEEE J Biomed Health Inform, 2025, 29:1886-1896. [13] Lorentzen R, Nguyen TD, McGirr A, Hieronymus F, Østergaard SD. The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis[J]. Schizophrenia (Heidelb), 2022, 8:35. [14] Kumpf U, Palm U, Eder J, Ezim H, Stadler M, Burkhardt G, Dechantsreiter E, Padberg F. TDCS at home for depressive disorders: an updated systematic review and lessons learned from a prematurely terminated randomized controlled pilot study [J]. Eur Arch Psychiatry Clin Neurosci, 2023, 273:1403-1420. [15] Zhou J, Li D, Ye F, Liu R, Feng Y, Feng Z, Li R, Li X, Liu J, Zhang X, Zhou J, Wang G. Effect of add-on transcranial alternating current stimulation (tACS) in major depressive disorder: a randomized controlled trial[J]. Brain Stimul, 2024, 17:760-768. [16] Ren C, Pagali SR, Wang Z, Kung S, Boyapati RB, Islam K, Li JW, Shelton KM, Waniger A, Rydberg AM, Hassett LC, Croarkin PE, Lundstrom BN, Pascual-Leone A, Lapid MI. Transcranial electrical stimulation in treatment of depression: a systematic review and Meta-analysis[J]. JAMA Netw Open, 2025, 8:e2516459. [17] Agboada D, Zhao Z, Wischnewski M. Neuroplastic effects of transcranial alternating current stimulation (tACS): from mechanisms to clinical trials[J]. Front Hum Neurosci, 2025, 19: 1548478. [18] Elyamany O, Leicht G, Herrmann CS, Mulert C. Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry[J]. Eur Arch Psychiatry Clin Neurosci, 2021, 271:135-156. [19] Yang C, Jung B, Lee SH. Transcranial electrical stimulation: clinical implication and practice for treatment of psychiatric illness[J]. Clin Psychopharmacol Neurosci, 2024, 22:391-404. [20] Wang T, Liu S, Guo XM, Zhang XC, Ming D. Application of exogenous rhythmic neuromodulation techniques for the treatment of neuropsychiatric diseases[J]. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Jin Zhan, 2023, 50:2262-2275.[王瞳, 刘爽, 郭欣萌, 张小臣, 明东. 外源节律性脑刺激技术在精神神经类疾病治疗中的应用[J]. 生物化学与生物物理进展, 2023, 50:2262-2275.] [21] Lakatos P, Gross J, Thut G. A new unifying account of the roles of neuronal entrainment[J]. Curr Biol, 2019, 29:R890-R905. [22] Gattas S, Elias GA, Janecek J, Yassa MA, Fortin NJ. Proximal CA120-40 Hz power dynamics reflect trial-specific information processing supporting nonspatial sequence memory[J]. Elife, 2022, 11:e55528. [23] Zhang XL, Yang QL, Si XY, Huang PS, Wang K, Miao Y, Dong QL. Research progress of transcranial alternating current stimulation in the treatment of cognitive impairment in neuropsychiatric diseases[J]. Zhongguo Shen Jing Jing Shen Ji Bing Za Zhi, 2024, 50:43-48.[张雪琳, 杨秋丽, 司夏樱, 黄佩姗, 王克, 苗懿, 董强利. 经颅交流电刺激治疗神经精神疾病认知功能损害研究进展[J]. 中国神经精神疾病杂志, 2024, 50:43-48.] [24] Riddle J, Alexander ML, Schiller CE, Rubinow DR, Frohlich F. Reduction in left frontal alpha oscillations by transcranial alternating current stimulation in major depressive disorder is context dependent in a randomized clinical trial [J]. Biol Psychiatry Cogn Neurosci Neuroimaging, 2022, 7:302-311. [25] Alexander ML, Alagapan S, Lugo CE, Mellin JM, Lustenberger C, Rubinow DR, Fröhlich F. Double-blind, randomized pilot clinical trial targeting alpha oscillations with transcranial alternating current stimulation (tACS) for the treatment of major depressive disorder (MDD)[J]. Transl Psychiatry, 2019, 9:106. [26] Gehrman PR, Bartky EJ, Travers C, Lapidus K. A fully remote randomized trial of transcranial alternating current stimulation for the acute treatment of major depressive disorder[J]. J Clin Psychiatry, 2024, 85:23m15078. [27] Zhang M, Force RB, Walker C, Ahn S, Jarskog LF, Frohlich F. Alpha transcranial alternating current stimulation reduces depressive symptoms in people with schizophrenia and auditory hallucinations: a double-blind, randomized pilot clinical trial [J]. Schizophrenia (Heidelb), 2022, 8:114. [28] Riddle J, Rubinow DR, Frohlich F. A case study of weekly tACS for the treatment of major depressive disorder[J]. Brain Stimul, 2020, 13:576-577. [29] Haller N, Senner F, Brunoni AR, Padberg F, Palm U. Gamma transcranial alternating current stimulation improves mood and cognition in patients with major depression[J]. J Psychiatr Res, 2020, 130:31-34. [30] Sprugnoli G, Munsch F, Cappon D, Paciorek R, Macone J, Connor A, El Fakhri G, Salvador R, Ruffini G, Donohoe K, Shafi MM, Press D, Alsop DC, Pascual Leone A, Santarnecchi E. Impact of multisession 40 Hz tACS on hippocampal perfusion in patients with Alzheimer's disease[J]. Alzheimers Res Ther, 2021, 13:203. [31] Shen SY, Liang LF, Shi TL, Shen ZQ, Yin SY, Zhang JR, Li W, Mi WL, Wang YQ, Zhang YQ, Yu J. Microglia-derived interleukin-6 triggers astrocyte apoptosis in the hippocampus and mediates depression-like behavior[J]. Adv Sci (Weinh), 2025, 12:e2412556. [32] Gulbaz ZU, Mirza S, Naveed S, Azeem MW, Husain N, Cheema MI. Towards objective major depressive disorder detection: a systematic review and Meta-analysis of diagnostic biomarkers [J]. Psychiatr Q, 2025.[Epub ahead of print] [33] Sánchez-Garrido Campos G, Zafra ÁM, Estévez-Rodríguez M, Cordones I, Ruffini G, Márquez -Ruiz J. Preclinical insights into gamma-tACS: foundations for clinical translation in neurodegenerative diseases [J]. Front Neurosci, 2025, 19: 1549230. [34] De Paolis ML, Paoletti I, Zaccone C, Capone F, D'Amelio M, Krashia P. Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's disease[J]. Transl Neurodegener, 2024, 13:33. [35] Wang H, Wang K, Xue Q, Peng M, Yin L, Gu X, Leng H, Lu J, Liu H, Wang D, Xiao J, Sun Z, Li N, Dong K, Zhang Q, Zhan S, Fan C, Min B, Zhou A, Xie Y, Song H, Ye J, Liu A, Gao R, Huang L, Jiao L, Song Y, Dong H, Tian Z, Si T, Zhang X, Li X, Kamiya A, Cosci F, Gao K, Wang Y. Transcranial alternating current stimulation for treating depression: a randomized controlled trial[J]. Brain, 2022, 145:83-91. [36] Liu J, Zhang X, Wei Y, Wu C, Yang P, Xu X, Sun Y, Zhong G, Du J. High-intensity transcranial alternating current stimulation for gambling disorder comorbidities with alcohol use disorders: a case report[J]. Am J Addict, 2026, 35:94-97. [37] Heise KF, Kortzorg N, Saturnino GB, Fujiyama H, Cuypers K, Thielscher A, Swinnen SP. Evaluation of a modified high-definition electrode montage for transcranial alternating current stimulation (tACS) of pre-central areas[J]. Brain Stimul, 2016, 9:700-704. [38] Zhang HY, Hou TT, Jin ZH, Zhang T, Wang YH, Cheng ZH, Liu YH, Fang JP, Yan HJ, Zhen Y, An X, Du J, Chen KK, Li ZZ, Li Q, Wen QP, Fang BY. Transcranial alternating current stimulation improves quality of life in Parkinson's disease: study protocol for a randomized, double-blind, controlled trial [J]. Trials, 2024, 25:200. [39] Luo J, Sun CC, Pan WG, Wang D, Shi XN, Wang Q, Jin WQ, Liang LR, Yang CL, Ma X, Ren YP. Efficacy and safety of transcranial alternating-current stimulation combined with antidepressants in the treatment of depressive episode[J]. Shou Du Yi Ke Da Xue Xue Bao, 2022, 43:244-248.[罗炯, 孙丛丛,潘伟刚, 王丹, 史晓宁, 王茜, 金文青, 梁立荣, 杨春林, 马辛,任艳萍. 经颅交流电刺激联合抗抑郁药对抑郁发作的疗效及安全性[J]. 首都医科大学学报, 2022, 43:244-248.] [40] Li D, Liu R, Ye F, Li R, Li X, Liu J, Zhang X, Zhou J, Wang G. Modulation of brain function and antidepressant effects by transcranial alternating current stimulation in patients with major depressive disorder: evidence from ERP[J]. J Psychiatr Res, 2024, 176:1-8. [41] Matsumoto H, Ugawa Y. Adverse events of tDCS and tACS: a review[J]. Clin Neurophysiol Pract, 2016, 2:19-25. [42] Yuan Z, Hu Y, Cheng D, Yang Y, Hong S, Kuang L. High-intensity transcranial alternating current stimulation combined with pharmacotherapy for adolescent major depressive disorder: a prospective case report study[J]. Front Psychiatry, 2025, 16: 1664698. [43] Zhang DW, Moraidis A, Klingberg T. Individually tuned theta HD -tACS improves spatial performance[J]. Brain Stimul, 2022, 15:1439-1447. [44] Raymond N, Reinhart RMG, Trotti R, Parker D, Grover S, Turkozer B, Sabatinelli D, Hegde R, Bannai D, Hoang D, Gandu S, Clementz B, Keshavan M, Lizano P. A pilot study to investigate the efficacy and tolerability of lesion network guided transcranial electrical stimulation in outpatients with psychosis spectrum illness[J]. Asian J Psychiatr, 2023, 88:103750. [45] Grossman N, Bono D, Dedic N, Kodandaramaiah SB, Rudenko A, Suk HJ, Cassara AM, Neufeld E, Kuster N, Tsai LH, Pascual-Leone A, Boyden ES. Noninvasive deep brain stimulation via temporally interfering electric fields[J]. Cell, 2017, 169:1029-1041. [46] Thiele C, Rufener KS, Repplinger S, Zaehle T, Ruhnau P. Transcranial temporal interference stimulation (tTIS) influences event-related alpha activity during mental rotation [J]. Psychophysiology, 2024, 61:e14651. [47] Demchenko I, Tailor I, Chegini S, Yu H, Gholamali Nezhad F, Rueda A, Kever A, Krishnan S, Datta A, Meltzer JA, Graham SJ, Schweizer TA, Rampersad S, Boyden ES, Violante IR, Chen R, Lozano AM, Bhat V. Human applications of transcranial temporal interference stimulation: a systematic review[J]. Brain Stimul, 2025, 18:2054-2066. [48] Botzanowski B, Acerbo E, Lehmann S, Kearsley SL, Steiner M, Neufeld E, Missey F, Muller L, Jirsa V, Corneil BD, Williamson A. Focal control of non-invasive deep brain stimulation using multipolar temporal interference[J]. Bioelectron Med, 2025, 1:7. [49] Wang Y, Zeng GQ, Wang M, Zhang M, Chang C, Liu Q, Wang K, Ma R, Wang Y, Zhang X. The safety and efficacy of applying a high-current temporal interference electrical stimulation in humans[J]. Front Hum Neurosci, 2024, 18: 1484593. [50] Zhou H, Wang M, Qi S, Chen Q, Lai J, Wu Z, Liu R, Wang L, Zhou H, Zhang S, Hu S. Transcranial temporal interference stimulation for treating bipolar disorder with depressive episodes: a feasibility study[J]. Mol Psychiatry, 2025, 30:6099-6106. |